Lyell Immunopharma, Inc. (LYEL) insider trading
Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 12, 2026.
- Filings shown
- 33
- Open-market buys
- 1
- Open-market sells
- 20
- Buys, 10b5-1 box not checked
- 1 of 1
Counts cover the 33 most recent Form 4 filings Tradune holds for LYEL (filed Jun 11 – Nov 12, 2026); the score below covers only the trailing 90 days (1 buy, 6 sells). SEC EDGAR Form 4 filings for LYEL last checked Nov 21, 2026, 09:00 UTC; the latest LYEL filing Tradune holds was filed Nov 12, 2026. This is not guaranteed to be the complete record — see LYEL's full Form 4 filing history on SEC EDGAR.
Open-market activity, last 90 days
Purchases (Form 4 code P) and sales (code S) on the 11 filings Tradune holds for LYEL filed Aug 25 – Nov 12, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.
9 open-market sales by Rule 10b5-1 checkbox
- On filings with the 10b5-1 box checked
- 0 sales· 0 sh
- checkbox disclosed
- On filings with the box not checked
- 9 sales· 14,135 sh
- not proof that no plan exists
- Not comparable
- 0 sales· 0 sh
- filed before Apr 1, 2023, or no checkbox value in the filing data
Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.
| Insider | Buys | Sells | Shares bought | Shares sold | Value |
|---|---|---|---|---|---|
| Lynn SeelyPresident and CEO | 0 | 2 | — | 10,134 | −$157,695 |
| Gary K. LeeChief Scientific Officer | 0 | 2 | — | 1,586 | −$24,697 |
| Stephen J. HillChief Operating Officer | 0 | 2 | — | 1,077 | −$16,771 |
| Arch Venture Fund Xiii, L.P.10% owner | 1 | 0 | 2,321,262 | — | +$24,999,992 |
| David ShookChief Medical Officer | 0 | 1 | — | 500 | −$6,350 |
| Jarrad Mattieu AguirreChief Medical Officer | 0 | 1 | — | 422 | −$3,642 |
| Veronica Sanchez BulisVP, Corporate Controller | 0 | 1 | — | 416 | −$6,627 |
Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.
Insider-activity score
39/ 100
Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →
Get alerted when insiders buy the stocks you own
Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.
Free for everyone right now · no card · nothing to buy
Weekly signal history
LYEL appeared in 1 archived weekly edition as a multi-insider cluster, a top net buyer, or both. These are frozen weekly snapshots, not a complete filing history.
- Week of Nov 10, 2026 2 insiders buying · $49,999,983 net 2 open-market buys · $49,999,983 net
An entry means this company met that edition’s displayed cluster or top-buyer threshold. Missing weeks do not mean no insider transaction occurred. All figures are derived from SEC Form 4 filings; open-market buys minus sales are shown as net only when every transaction value was disclosed.
How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).
Insider Buying at LYEL
Insiders reported 1 open-market purchase of LYEL between Jun 11, 2026 and Nov 12, 2026, across 1 distinct buyer. The most recent purchase was reported by Arch Venture Fund Xiii, L.P. (10% owner) on Nov 4, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Recent Form 4 filings
Source: SEC EDGAR Form 4 · transaction codes explained
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 416 | $15.93 | 14,383 | −2.8% | Nov 10, 2026 |
† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.
“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 129 | $15.93 | 16,091 | −0.8% | Nov 10, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 88 | $15.93 | 16,728 | −0.5% | Nov 10, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 545 | $15.93 | 63,354 | −0.9% | Nov 10, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 2,321,262 | $10.77 | 3,747,790 (indirect) | +163% | Nov 4, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 422 | $8.63 | 19,857 | −2.1% | Oct 12, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Option (right to buy) | 47,500 | — | — | — | Sep 10, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 500 | $12.70 | 20,423 | −2.4% | Sep 10, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 1,457 | $15.54 | 16,220 | −8.2% | Aug 21, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 989 | $15.54 | 16,816 | −5.6% | Aug 21, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 9,589 | $15.54 | 63,899 | −13% | Aug 21, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 621 | $14.34 | 14,799 | −4.0% | Aug 10, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 131 | $14.34 | 17,677 | −0.7% | Aug 10, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 89 | $14.34 | 17,805 | −0.5% | Aug 10, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 390 | $14.34 | 73,488 | −0.5% | Aug 10, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Other acquisition / disposition | 44,000 | — | 2,774,980 | −1.6% | Jul 27, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Other acquisition / disposition | 38,500 | — | 2,818,980 | −1.3% | Jul 27, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 10 | $13.70 | 2,857,480 | −0.0% | Jul 17, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 10 | $13.73 | 2,857,490 | −0.0% | Jul 16, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Other acquisition / disposition | 76,000 | — | 2,857,500 | −2.6% | Jun 29, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Other acquisition / disposition | 66,500 | — | 2,933,500 | −2.2% | Jun 15, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 217 | $18.91 | 15,420 | −1.4% | May 11, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 130 | $18.92 | 17,808 | −0.7% | May 11, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 89 | $18.92 | 17,894 | −0.5% | May 11, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 388 | $18.91 | 73,878 | −0.5% | May 11, 2026 |
Listing the 25 most recent of 33 Form 4 filings held for LYEL; the 8 older filings (filed Jun 11 – Jun 12, 2026) are counted above but not listed here — see LYEL's full Form 4 filing history on SEC EDGAR.
Insider filings reported around the same time
Other companies whose most recent Form 4 was filed closest to LYEL's (Nov 12, 2026).
Frequently asked about LYEL insider activity
How many insiders bought LYEL stock in these Form 4 filings?
1 distinct insider at Lyell Immunopharma, Inc. reported 1 open-market purchase (Form 4 code P) of LYEL shares between Jun 11, 2026 and Nov 12, 2026, the most recent filed by Arch Venture Fund Xiii, L.P. (10% owner) on Nov 4, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Who filed the most recent Form 4 for LYEL?
The most recent Form 4 on this page was filed by Lynn Seely (President and CEO) on Nov 12, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.
What was the largest open-market LYEL insider purchase shown?
The largest open-market purchase among the filings shown was 2,321,262 LYEL shares at $10.77 (about $24,999,992) by Arch Venture Fund Xiii, L.P. (10% owner) on Nov 4, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.
Do the recent LYEL insider purchases have the Form 4 10b5-1 box checked?
No. The one LYEL open-market purchase shown was reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Arch Venture Fund Xiii, L.P. (10% owner) on Nov 4, 2026, 2,321,262 shares.
New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.
Get insider alerts for LYEL — and your whole portfolio
Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy
This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.
Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.